Real-world data from Novo Nordisk suggests that ozempic may be effective for weight loss, but the extent of its effectiveness compared to eli lilly's mounjaro is unclear. Some reports indicate that mounjaro may be more effective for weight loss in certain adults, while other data suggests that patients may be able to maintain weight loss after stopping a glp-1 medication. The relative effectiveness of these medications is still being studied and debated.